A phase 1 trial of α-lactalbumin vaccine for the treatment of patients with triple-negative breast cancer demonstrated safety ...
Because of their anatomy, “they're going to be the hardest to treat with ... and we know it feels a lot better,” says Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback